Skip to main content
Top
Published in: BMC Pediatrics 1/2013

Open Access 01-12-2013 | Research article

Active trachoma two years after three rounds of azithromycin mass treatment in Cheha district Gurage zone, Southern Ethiopia

Authors: Fisseha Admassu, Samson Bayu, Abebe Bejiga, Bemnet Amare

Published in: BMC Pediatrics | Issue 1/2013

Login to get access

Abstract

Background

Azithromycin mass distribution was given to residents of Gurage zone Cheha district in 2004, 2005 and 2006 for three consecutive years with more than 90% coverage. The effect of treatment in the study community was not yet determined. The present study was therefore designed to assess the effect of azithromycin on the prevalence of active trachoma two years after three rounds of mass treatment of the community at Cheha district, Gurage zone.

Methods

A multistage stratified cluster random survey was employed to determine the prevalence of active trachoma among children aged 1 to 9. Selected children were examined for trachoma using the simplified WHO grading system and their households were assessed for trachoma risk factors.

Results

This survey demonstrated that the prevalence of active trachoma in the study community was 22.8% (95% CI 18.24% - 27.36%) that was lower than that of Southern Nations, Nationalities, and People's Regional prevalence (33.2%) in 2006. Only 27.6% (95% CI 25.7% - 30.1%) of the study population had a safe and clean water supply, whereas 42.7% (95% CI 39.8% - 46.2%) of the visited households had simple pit latrines.

Conclusion

This survey demonstrated that despite repeated mass oral azithromycin distributions, the prevalence of active trachoma was still high. Therefore, the other components of the SAFE strategy such as fly control program, improving the water sources, measures to improve face washing and construction of utilizable latrines that are being implemented through the health extension package have to be integrated with mass azithromycin treatment to eliminate active trachoma in the district.
Appendix
Available only for authorised users
Literature
1.
go back to reference Chandler RD: Duane’s Clinical Ophthalmology, Volume 5. Pathogenesis and Control of Blinding Trachoma. 2005, New York: Lippincot Williams and Wilkins, Clinical, Chapter 60 Chandler RD: Duane’s Clinical Ophthalmology, Volume 5. Pathogenesis and Control of Blinding Trachoma. 2005, New York: Lippincot Williams and Wilkins, Clinical, Chapter 60
3.
go back to reference Resnikoff S, Pascolini D, Etya’ale D, Kocur I, Pararajasegaram R, et al: Global data on visual impairment in the year 2002. Bull World Health Organ. 2004, 82: 844-851.PubMedPubMedCentral Resnikoff S, Pascolini D, Etya’ale D, Kocur I, Pararajasegaram R, et al: Global data on visual impairment in the year 2002. Bull World Health Organ. 2004, 82: 844-851.PubMedPubMedCentral
4.
go back to reference Burton MJ, Holland MJ, Makalo P, Aryee EAN, Sillah A, et al: Profound and Sustained Reduction in Chlamydia trachomatis in The Gambia: a five-year longitudinal study of trachoma endemic communities. PLoS Negl Trop Dis. 2010, 4 (10): e835-10.1371/journal.pntd.0000835.CrossRefPubMedPubMedCentral Burton MJ, Holland MJ, Makalo P, Aryee EAN, Sillah A, et al: Profound and Sustained Reduction in Chlamydia trachomatis in The Gambia: a five-year longitudinal study of trachoma endemic communities. PLoS Negl Trop Dis. 2010, 4 (10): e835-10.1371/journal.pntd.0000835.CrossRefPubMedPubMedCentral
5.
go back to reference Mariotti SP: New steps toward eliminating blinding trachoma. N Engl J Med. 2004, 351: 2004-2007. 10.1056/NEJMe048205.CrossRefPubMed Mariotti SP: New steps toward eliminating blinding trachoma. N Engl J Med. 2004, 351: 2004-2007. 10.1056/NEJMe048205.CrossRefPubMed
6.
go back to reference Gaynor BD, Yi E, Lietman T: Rationale for mass antibiotic distribution for trachoma elimination. Int Ophthalmol Clin. 2002, 42: 85-92. 10.1097/00004397-200201000-00012.CrossRefPubMed Gaynor BD, Yi E, Lietman T: Rationale for mass antibiotic distribution for trachoma elimination. Int Ophthalmol Clin. 2002, 42: 85-92. 10.1097/00004397-200201000-00012.CrossRefPubMed
8.
go back to reference Schachter J, West SK, Mabey D, et al: Azithromycin in control of trachoma. Lancet. 1999, 354: 630-635. 10.1016/S0140-6736(98)12387-5.CrossRefPubMed Schachter J, West SK, Mabey D, et al: Azithromycin in control of trachoma. Lancet. 1999, 354: 630-635. 10.1016/S0140-6736(98)12387-5.CrossRefPubMed
9.
go back to reference Numazaki K, Ikehata M, Chiba S, Aoki K: Reduction of trachoma in absence of a disease-control programme. Lancet. 1997, 350: 447-448.CrossRefPubMed Numazaki K, Ikehata M, Chiba S, Aoki K: Reduction of trachoma in absence of a disease-control programme. Lancet. 1997, 350: 447-448.CrossRefPubMed
10.
go back to reference Central Statistical Agency [Ethiopia] and ICF International: Central Statistical Agency [Ethiopia] and ICF International: Ethiopia Demographic and Health Survey 2005. 2005, Maryland: Addis Ababa, Ethiopia and Calverton Central Statistical Agency [Ethiopia] and ICF International: Central Statistical Agency [Ethiopia] and ICF International: Ethiopia Demographic and Health Survey 2005. 2005, Maryland: Addis Ababa, Ethiopia and Calverton
11.
go back to reference Daniel W: Biostatistics- a foundation for analysis in health sciences. Determination of Sample Size for Estimating Means. 1995, New York: Lippincot, 180-6 Daniel W: Biostatistics- a foundation for analysis in health sciences. Determination of Sample Size for Estimating Means. 1995, New York: Lippincot, 180-6
12.
go back to reference Berhane Y, Worku A, Bejiga A, Liknaw A, Wondu A, Badri A, Haile Z, Ayalew A, Adamu Y, GETBe T, Kebede TD, West E, West S: Prevalence and causes of blindness and Low vision in Ethiopia. Ethiop J Health Dev. 2007, 21 (3): 211-215. Berhane Y, Worku A, Bejiga A, Liknaw A, Wondu A, Badri A, Haile Z, Ayalew A, Adamu Y, GETBe T, Kebede TD, West E, West S: Prevalence and causes of blindness and Low vision in Ethiopia. Ethiop J Health Dev. 2007, 21 (3): 211-215.
13.
go back to reference Khandekarf R, Mohammed AJ: Outcome of azithromycin treatment of active trachoma in Omani school children. E Med Health J. 2003, 9 (5–6): 1026-1033. Khandekarf R, Mohammed AJ: Outcome of azithromycin treatment of active trachoma in Omani school children. E Med Health J. 2003, 9 (5–6): 1026-1033.
14.
go back to reference Thylefors B, Dawson CR, Jones BR, West SK, Taylor HR: A simple system for the assessment of trachoma and its complications. Bull World Health Organ. 1987, 65: 477-483.PubMedPubMedCentral Thylefors B, Dawson CR, Jones BR, West SK, Taylor HR: A simple system for the assessment of trachoma and its complications. Bull World Health Organ. 1987, 65: 477-483.PubMedPubMedCentral
15.
go back to reference Chidambaram JD, Alemayehu W, Melese M, Lakew T, Yi E, House J, et al: Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma. JAMA. 2006, 295 (10): 1142-1146. 10.1001/jama.295.10.1142.CrossRefPubMed Chidambaram JD, Alemayehu W, Melese M, Lakew T, Yi E, House J, et al: Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma. JAMA. 2006, 295 (10): 1142-1146. 10.1001/jama.295.10.1142.CrossRefPubMed
16.
go back to reference Ngondi J, Matthews F, Reacher M, Baba S, Brayne C, Emerson P: Associations between Active Trachoma and Community Intervention with Antibiotics, Facial Cleanliness, and Environmental Improvement (A, F, E). PLoS Negl trop dis. 2008, 2 (4): e229-10.1371/journal.pntd.0000229.CrossRefPubMedPubMedCentral Ngondi J, Matthews F, Reacher M, Baba S, Brayne C, Emerson P: Associations between Active Trachoma and Community Intervention with Antibiotics, Facial Cleanliness, and Environmental Improvement (A, F, E). PLoS Negl trop dis. 2008, 2 (4): e229-10.1371/journal.pntd.0000229.CrossRefPubMedPubMedCentral
17.
go back to reference Melese M, Chidambaram JD, Alemayehu W, Lee DC, Yi EH, et al: Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments. JAMA. 2004, 292: 721-725. 10.1001/jama.292.6.721.CrossRefPubMed Melese M, Chidambaram JD, Alemayehu W, Lee DC, Yi EH, et al: Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments. JAMA. 2004, 292: 721-725. 10.1001/jama.292.6.721.CrossRefPubMed
18.
go back to reference Melese M, Alemayehu W, Lakew T, Yi E, House JI, et al: Comparison of annual and biannual mass antibiotic administration for elimination of infectious trachoma. JAMA. 2008, 299: 778-784. 10.1001/jama.299.7.778.CrossRefPubMed Melese M, Alemayehu W, Lakew T, Yi E, House JI, et al: Comparison of annual and biannual mass antibiotic administration for elimination of infectious trachoma. JAMA. 2008, 299: 778-784. 10.1001/jama.299.7.778.CrossRefPubMed
19.
20.
go back to reference West SK, Munoz B, Mkocha H, Holland MJ, Aguirre A, et al: Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study. Lancet. 2005, 366: 1296-1300. 10.1016/S0140-6736(05)67529-0.CrossRefPubMed West SK, Munoz B, Mkocha H, Holland MJ, Aguirre A, et al: Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study. Lancet. 2005, 366: 1296-1300. 10.1016/S0140-6736(05)67529-0.CrossRefPubMed
21.
go back to reference Lietman T, Porco T, Dawson C, Blower S: Global elimination of trachoma: how frequently should we administer mass chemotherapy?. Nat Med. 1999, 5: 572-576. 10.1038/8451.CrossRefPubMed Lietman T, Porco T, Dawson C, Blower S: Global elimination of trachoma: how frequently should we administer mass chemotherapy?. Nat Med. 1999, 5: 572-576. 10.1038/8451.CrossRefPubMed
Metadata
Title
Active trachoma two years after three rounds of azithromycin mass treatment in Cheha district Gurage zone, Southern Ethiopia
Authors
Fisseha Admassu
Samson Bayu
Abebe Bejiga
Bemnet Amare
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2013
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/1471-2431-13-199

Other articles of this Issue 1/2013

BMC Pediatrics 1/2013 Go to the issue